← SynDRA
MIRIN
SynDRA canonical compound SYN0020238 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MRE11A |
|---|
| Mechanism of action | MRE11A exonuclease inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MRE11A exonuclease inhibitor
Cross-references
Synonyms
- 2-Amino-5-[(4-hydroxyphenyl)methylene]-4(5H)-thiazolone
- 2-Amino-5-((4-hydroxyphenyl)methylene)-4(5H)-thiazolone
- RefChem:159046
- DTXCID30285449
- YBHQCJILTOVLHD-YVMONPNESA-N
- (Z)-Mirin
- Z-5-(4-Hydroxybenzylidene)-2-imino-1,3-thiazolidin-4-one
- MRN-ATM Pathway Inhibitor, Mirin
- (Z)-5-(4-Hydroxybenzylidene)-2-iminothiazolidin-4-one
- SCHEMBL15421605
- CHEBI:188315
- HMS3648I06
- EX-A2499
- Mirin, >=98% (HPLC), powder
- s8096
- STK804652
- AKOS002209500
- AKOS003095676
- D83653
- SR-01000946371
- SR-01000946371-1
- BRD-K55420858-001-01-0
- (5Z)-5-(4-hydroxybenzylidene)-2-imino-1,3-thiazolidin-4-one
- MFCD05885480
- (Z)-2-amino-5-(4-hydroxybenzylidene)thiazol-4(5H)-one
- orb1304504
- YXB09797
- ZLA95300
- CCG-208657
- AC-32950
- AS-55824
- M3303
- (5Z)-2-amino-5-[(4-hydroxyphenyl)methylene]thiazol-4-one
Look up MIRIN in the interactive SynDRA portal →